Data from Phase 1 clinical trial of ATH-1105 in healthy volunteers showed a favorable safety and tolerability profile; dose proportional pharmacokinetics and CNS penetration support continued ...

Nimbus will present preclinical data on NTX-452, a novel WRN inhibitor developed using the company's computational drug discovery platform.

ProBio will showcase pre-clinical in vitro and in vivo data demonstrating the potential of its innovative CD3 agonistic single-domain antibody (sdAb/VHH) as a foundational component for advancing ...

Purdue University’s Data and AI Storytelling Certificate is an online professional development opportunity that teaches people who work with data how to craft persuasive narratives, visualize data ...

Beam Therapeutics will present new BEAM-101 data for sickle cell disease at EHA2025, detailing safety and efficacy in 17 patients.

Ardelyx will present data on IBSRELA® at Digestive Disease Week, highlighting its safety and effectiveness for IBS-C treatment.